Association between serum levels of soluble tumor necrosis factor receptors/CA 125 and disease progression in patients with epithelial ovarian malignancy: a gynecologic oncology group study

Cancer
Robert A BurgerDavid E Cohn

Abstract

A prospective study was undertaken within the Gynecologic Oncology Group to determine whether serum levels of soluble tumor necrosis factor receptors I (sTNFR-I) and II (sTNFR-II), alone or in combination with CA 125, were associated with clinicopathologic characteristics or outcome in patients with epithelial ovarian malignancies. Quantitative immunoassays were performed on valid pretreatment serum specimens obtained from patients with epithelial ovarian malignancies to assess levels of sTNFR-I, sTNFR-II, and CA 125. The authors then analyzed the results of these immunoassays for potential correlations with clinicopathologic characteristics and outcome. The median age of the 139 women evaluated was 59 years. Seventy-eight percent had Stage III or IV disease, and 58% had serous carcinomas. sTNFR-II was associated with age (P = 0.013), and CA 125 was associated with histologic subtype (P = 0.0009). In addition, sTNFR-I (P = 0.037) and CA 125 (P < 0.0001) were associated with extent of disease. After adjusting for patient age, histologic subtype, and extent of disease, all three biomarkers were predictive of progression-free survival, but not overall survival, when the combination was included in the model. The authors observed a...Continue Reading

References

May 1, 1992·Immunology Today·L A Tartaglia, D V Goeddel
Jan 1, 1991·Clinical Oncology : a Journal of the Royal College of Radiologists·N G DavidsonD Bircumshaw
Aug 1, 1990·Proceedings of the National Academy of Sciences of the United States of America·R A HellerG M Ringold
Nov 1, 1990·Proceedings of the National Academy of Sciences of the United States of America·T KohnoJ L Vannice
Mar 1, 1989·European Journal of Haematology·I OlssonG Adolf
Oct 13, 1983·The New England Journal of Medicine·R C BastR C Knapp
Oct 1, 1994·British Journal of Obstetrics and Gynaecology·D ParkerJ J Price
Jan 1, 1994·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·U Elsässer-BeileS von Kleist
May 1, 1993·The Journal of Clinical Investigation·M S NaylorF R Balkwill
Nov 1, 1995·Journal of Interferon & Cytokine Research : the Official Journal of the International Society for Interferon and Cytokine Research·D A Joyce, J H Steer
Jan 1, 1996·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·M OnsrudR Austgulen
May 15, 1996·Biochemical and Biophysical Research Communications·K KatsuraT Gatanaga
Sep 1, 2001·Molecular Cell Biology Research Communications : MCBRC·K Heyninck, R Beyaert
Sep 2, 2003·Nature Reviews. Immunology·Bharat B Aggarwal
Sep 11, 2003·The Lancet Oncology·Peter W Szlosarek, Frances R Balkwill

❮ Previous
Next ❯

Citations

Nov 16, 2004·Menopause : the Journal of the North American Menopause Society·Alessandra Graziottin, Rosemary Basson
Oct 13, 2009·Journal of Ovarian Research·Digant Gupta, Christopher G Lis
Jan 1, 2009·Folia Histochemica Et Cytobiologica·Bozena DobrzyckaLech Chyczewski
Jan 1, 2006·Women's Health·Angiolo GadducciAndrea Riccardo Genazzani
Oct 22, 2008·Seminars in Oncology·George A Omura, UNKNOWN Gynecologic Oncology Group
Aug 18, 2005·American Journal of Reproductive Immunology : AJRI·Judith L LuborskyJacob Rotmensch
Apr 29, 2011·European Journal of Heart Failure·Mehmet Birhan YilmazAlain Cohen Solal
Aug 7, 2021·Frontiers in Cardiovascular Medicine·Yi ZhangZhihong Liu

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
Robert C BastKaren H Lu
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
Russell J SchilderBarbara C Vanderhyden
Proceedings of the National Academy of Sciences of the United States of America
Gil MorDavid C Ward
© 2022 Meta ULC. All rights reserved